-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIDGEBIO PHARMA, - ANNOUNCES PRICING OF 5,000,000 SHARE SECONDARY OFFERING BY KKR GENETIC DISORDER L.P.

Reuters·08/14/2026 11:30:00

Please log in to view news